| Dr Dana C Baras, MD | |
|
7625 Maple Lawn Blvd Lowr Lobby, Fulton, MD 20759-2565 | |
| (410) 531-7557 | |
| (410) 531-0818 |
| Full Name | Dr Dana C Baras |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 7625 Maple Lawn Blvd Lowr Lobby, Fulton, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053573501 | NPI | - | NPPES |
| 338419500 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | D0074748 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.
As lawsuits over early abortion laws spring up across the country, the Supreme Court on Monday agreed to hear a different kind of abortion challenge -; this one involving free speech. The court will consider a case challenging a Massachusetts law that bans demonstrations within 35 feet of entrances and driveways of abortion clinics. The 1st Circuit Court of Appeals in January sided with the state in McCullen v. Coakley, ruling that the law strikes the right balance between protecting free speech and patients' rights (Millman, 6/25).
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.
Planetree, a non-profit organization facilitating efforts to create patient-centered care in healing environments, has entered into a new strategic business alliance with the Case Management Society of America (CMSA), the nation's largest multi-disciplinary professional association for case management.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
› Verified 3 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20050804000705 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.
As lawsuits over early abortion laws spring up across the country, the Supreme Court on Monday agreed to hear a different kind of abortion challenge -; this one involving free speech. The court will consider a case challenging a Massachusetts law that bans demonstrations within 35 feet of entrances and driveways of abortion clinics. The 1st Circuit Court of Appeals in January sided with the state in McCullen v. Coakley, ruling that the law strikes the right balance between protecting free speech and patients' rights (Millman, 6/25).
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.
Planetree, a non-profit organization facilitating efforts to create patient-centered care in healing environments, has entered into a new strategic business alliance with the Case Management Society of America (CMSA), the nation's largest multi-disciplinary professional association for case management.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
› Verified 3 days ago
| Entity Name | Hcgh Ob Gyn Associates Series |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629091079 PECOS PAC ID: 3971605999 Enrollment ID: O20070222000271 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.
As lawsuits over early abortion laws spring up across the country, the Supreme Court on Monday agreed to hear a different kind of abortion challenge -; this one involving free speech. The court will consider a case challenging a Massachusetts law that bans demonstrations within 35 feet of entrances and driveways of abortion clinics. The 1st Circuit Court of Appeals in January sided with the state in McCullen v. Coakley, ruling that the law strikes the right balance between protecting free speech and patients' rights (Millman, 6/25).
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.
Planetree, a non-profit organization facilitating efforts to create patient-centered care in healing environments, has entered into a new strategic business alliance with the Case Management Society of America (CMSA), the nation's largest multi-disciplinary professional association for case management.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana C Baras, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Dr Dana C Baras, MD 7625 Maple Lawn Blvd Lowr Lobby, Fulton, MD 20759-2565 Ph: (410) 531-7557 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.
As lawsuits over early abortion laws spring up across the country, the Supreme Court on Monday agreed to hear a different kind of abortion challenge -; this one involving free speech. The court will consider a case challenging a Massachusetts law that bans demonstrations within 35 feet of entrances and driveways of abortion clinics. The 1st Circuit Court of Appeals in January sided with the state in McCullen v. Coakley, ruling that the law strikes the right balance between protecting free speech and patients' rights (Millman, 6/25).
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.
Planetree, a non-profit organization facilitating efforts to create patient-centered care in healing environments, has entered into a new strategic business alliance with the Case Management Society of America (CMSA), the nation's largest multi-disciplinary professional association for case management.
Gen-Probe's PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco.
› Verified 3 days ago
Dr. Lilja S. Stefansson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8171 Maple Lawn Blvd Ste 100, Fulton, MD 20759 Phone: 410-531-7557 Fax: 410-531-0818 | |
Dr. Suzanne Aly Abdelazim, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7625 Maple Lawn Blvd Ste 1, Fulton, MD 20759 Phone: 410-531-7557 Fax: 410-531-0818 | |
Mark A Esposito, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7625 Maple Lawn Blvd, Ste 1 Lower Lobby, Fulton, MD 20759 Phone: 410-531-7557 Fax: 410-531-0818 | |
Nicole D Pilevsky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7625 Maple Lawn Bouelevard, Ste 1 Lower Lobby, Fulton, MD 20759 Phone: 410-531-7557 Fax: 410-531-0818 | |
Marvin P Davis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7625 Maple Lawn Blvd, Ste 1, Lower Level, Fulton, MD 20759 Phone: 410-531-7557 Fax: 410-531-0818 | |
Dr. Marc Loring Chaiken, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7625 Maple Lawn Blvd, Suite 1, Fulton, MD 20759 Phone: 410-531-0818 Fax: 410-531-0818 |